Zhende Medical Hits Day High with Strong 5.06% Intraday Surge

Zhende Medical Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable uptick in its stock performance today, gaining 5.06% as of March 11, 2026. The stock reached an intraday high of CNY 98.49, reflecting a strong day of trading activity. In terms of performance metrics, Zhende Medical has outperformed the China Shanghai Composite index significantly over various time frames. Over the past year, the stock has surged by 350.35%, while the composite index has only seen a 22.3% increase. Year-to-date, the stock has risen by 36.38%, compared to the composite's 4.15%. Despite these impressive short-term gains, the company faces challenges in long-term growth, with net sales declining at an annual rate of 13.03% over the last five years. The current market capitalization stands at CNY 19,569 million, and the stock exhibits a price-to-earnings ratio of 31.00. Additionally, the company maintains a high dividend yield of 0.89%, which may appeal to certain segments of the market.